Not applicableStudy completedNCT01746147
What this trial is testing
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial
Who this might be right for
MDS and AML Prior to Allogeneic SCT
GWT-TUD GmbH 134